Indian drug makers like Lupin, Dr Reddy’s, Sun Pharma, among others have placed bets on specialty drugs that are protected by patents as strategy to mitigate the rapid price erosion and commoditization of plain vanilla generic drugs in the US.
Copyright © 2024 | WordPress Theme by MH Themes